The knee is showing some signs of improvement but still far from being 100%
If phase 3 data replicates the Jastreboff phase 2 outcomes (24.2% weight loss sustained over 48 weeks) and achieves regulatory approval from the MHRA and EMA by 20272028, two pricing scenarios emerge: Scenario 1 (prescription approval): Retatrutide becomes a prescription-only medicine
Newer compounds like retatrutide act on three receptors simultaneously (GLP-1, GIP, and glucagon), combining appetite suppression with increased energy expenditure
Additionally, it can boost the immune system, improve skin health, and provide a natural energy boost
Its important for vitamin B12 or folate deficiency anaemia to be diagnosed and treated as soon as possible
There are times when symptoms get worse, known as flares, and times when there are no symptoms, known as remission